You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Interprofessional Clinic: A Team-Based Approach to Oral Therapies in Prostate Cancer

  • Authors: Karim Fizazi, MD, PhD; Emily Lemke, DNP; Katie P. Morgan, PharmD, BCOP, CPP
  • CME / ABIM MOC / CE Released: 4/1/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/1/2023, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of global oncologists, urologists, nurses, nurse practitioners, pharmacists, and other interprofessional healthcare providers who care for individuals with prostate cancer.

The goal of this activity is that physicians, nursing professionals, and pharmacists will be better able to understand the current and emerging approaches with oral antiandrogen therapies in the management of prostate cancer and discuss collaborative approaches to care.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Treatment-related adverse events associated with oral antiandrogen therapies used in patients with prostate cancer
  • Have greater competence related to
    • Individualizing therapy selection reflective of patient-specific factors, such as comorbidities and potential for drug-drug interactions
  • Demonstrate greater confidence in their ability to
    • Use an interprofessional team-based approach to optimally manage oral antiandrogen therapies in patients with prostate cancer


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Karim Fizazi, MD, PhD

    Professor of Medicine
    University of Paris-Saclay
    Head
    Department of Cancer Medicine
    Institut Gustave Roussy
    President
    Groupe d’Etude des Tumeurs Genito-Urinaires (GETUG)
    Villejuif, France

    Disclosures

    Consultant or advisor for: Amgen; Astellas; AstraZeneca; Bayer; CureVac; Janssen; Orion; Sanofi

  • Emily Lemke, DNP

    Nurse Practitioner
    Medical College of Wisconsin Cancer Center
    Milwaukee, Wisconsin

    Disclosures

    No relevant financial relationships.

  • Katie P. Morgan, PharmD, BCOP, CPP

    Hematology/Oncology Clinical Pharmacy Specialist
    The University of North Carolina Medical Center
    Chapel Hill, North Carolina

    Disclosures

    No relevant financial relationships.

Editors

  • Davecia Ragoonath Cameron, MS

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Davecia Ragoonath Cameron, MS, has no relevant financial relationships.

  • Jason Luis Quiñones, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Jason Luis Quiñones, PhD, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-22-078-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Interprofessional Clinic: A Team-Based Approach to Oral Therapies in Prostate Cancer

Authors: Karim Fizazi, MD, PhD; Emily Lemke, DNP; Katie P. Morgan, PharmD, BCOP, CPPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 4/1/2022

Valid for credit through: 4/1/2023, 11:59 PM EST

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print